Healthequity Inc (NASDAQ:HQY) – Cantor Fitzgerald increased their FY2019 earnings per share estimates for Healthequity in a research report issued on Wednesday. Cantor Fitzgerald analyst S. Halper now expects that the company will post earnings per share of $1.00 for the year, up from their prior estimate of $0.90. Cantor Fitzgerald has a “Overweight” rating and a $60.00 price objective on the stock.
Other analysts have also recently issued reports about the company. Citigroup started coverage on Healthequity in a report on Thursday, January 4th. They set a “buy” rating for the company. Chardan Capital lifted their price target on Healthequity from $58.00 to $62.00 and gave the stock a “buy” rating in a report on Wednesday, December 6th. Zacks Investment Research raised Healthequity from a “hold” rating to a “buy” rating and set a $60.00 price target for the company in a report on Wednesday, November 8th. BidaskClub raised Healthequity from a “sell” rating to a “hold” rating in a report on Tuesday, November 7th. Finally, Robert W. Baird lifted their price target on Healthequity from $48.00 to $49.00 and gave the stock a “neutral” rating in a report on Wednesday. Three equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. The company has an average rating of “Buy” and a consensus target price of $57.17.
Healthequity (NASDAQ:HQY) last released its quarterly earnings results on Tuesday, December 5th. The company reported $0.17 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.13 by $0.04. The business had revenue of $56.80 million during the quarter, compared to analysts’ expectations of $55.27 million. Healthequity had a return on equity of 14.47% and a net margin of 21.08%. The firm’s revenue for the quarter was up 31.0% compared to the same quarter last year. During the same period last year, the firm posted $0.10 EPS.
Several institutional investors and hedge funds have recently modified their holdings of HQY. Eagle Asset Management Inc. bought a new position in shares of Healthequity in the 3rd quarter valued at $36,875,000. Victory Capital Management Inc. grew its position in Healthequity by 116.4% during the 4th quarter. Victory Capital Management Inc. now owns 1,031,711 shares of the company’s stock worth $48,139,000 after acquiring an additional 555,027 shares during the last quarter. Wells Fargo & Company MN grew its position in Healthequity by 49.5% during the 3rd quarter. Wells Fargo & Company MN now owns 1,108,410 shares of the company’s stock worth $56,063,000 after acquiring an additional 366,925 shares during the last quarter. BlackRock Inc. grew its position in Healthequity by 3.8% during the 4th quarter. BlackRock Inc. now owns 6,751,491 shares of the company’s stock worth $315,026,000 after acquiring an additional 244,819 shares during the last quarter. Finally, Amussen Hunsaker & Associates LLC bought a new stake in Healthequity during the 2nd quarter worth $11,598,000. Institutional investors own 98.20% of the company’s stock.
In other Healthequity news, Director Frank Medici sold 700 shares of Healthequity stock in a transaction on Wednesday, November 15th. The stock was sold at an average price of $51.05, for a total value of $35,735.00. Following the completion of the transaction, the director now directly owns 6,381 shares of the company’s stock, valued at approximately $325,750.05. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Delano Ladd sold 26,405 shares of Healthequity stock in a transaction on Tuesday, December 12th. The shares were sold at an average price of $43.32, for a total value of $1,143,864.60. Following the completion of the transaction, the executive vice president now owns 16,692 shares in the company, valued at approximately $723,097.44. The disclosure for this sale can be found here. Insiders sold a total of 371,426 shares of company stock valued at $18,749,703 over the last ninety days. Insiders own 29.00% of the company’s stock.
Healthequity Company Profile
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.